<unk>  is a thrombopoietic growth factor that is FDA approved for the prophylaxis of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include rash, candidiasis, nausea, oral candidiasis, vomiting, dizziness, fatigue, headache, blurred vision, conjunctival hyperemia and dyspnea.
Oprelvekin
Bergapten
Irofulven
Bioallethrin
Iofendylate
Guanadrel
Poractant Alfa
Netarsudil